Journal profile · Gastroenterology & Hepatology
Annals of Hepatology
ISSN 1665-2681 · eISSN 2659-5982 · Mexican Association of Hepatology · MEXICO · Quarterly · Founded 2002
Annals of Hepatology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 5.87; fully open access; APC about USD 1,500; median 71 days to acceptance (107 articles, last 24 months); community-reported acceptance: fairly easy; 387 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Annals of Hepatology is published by Mexican Association of Hepatology and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation and Hepatitis C virus research, together about 48.8% of its articles. Its main subfields are Hepatology. (generated from OpenAlex topic counts and CAS ranking data)
Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of hepatology. Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). The journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.
From the journal's Aims & Scope
Research area (LetPub): Gastroenterology & Hepatology
Editor-in-chief Norberto C. Chávez-TapiaPublisher website
Editorial board by country: none in mainland China; most named Mexico 13, Italy 7, Spain 7, United States 3, Japan 2 (45 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Liver Disease Diagnosis and TreatmentMedicine24.5%
- Liver Disease and TransplantationMedicine14.8%
- Hepatitis C virus researchMedicine9.5%
- Hepatitis B Virus StudiesMedicine6.3%
- Liver Diseases and ImmunityMedicine5.3%
- Organ Transplantation Techniques and OutcomesMedicine5.1%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine4.7%
- Drug-Induced Hepatotoxicity and ProtectionPharmacology, Toxicology and Pharmaceutics3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Gastroenterology & Hepatology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.87LetPub ·
- Impact factor (publisher)
- 6.2Publisher website ·
- CiteScore 2026-06
- 9.6LetPub ·
- CiteScore (publisher)
- 9.6Publisher website ·
- SJR 2026-06
- 1.45LetPub ·
- SNIP 2026-06
- 1.38LetPub ·
- h-index
- 44LetPub ·
- h-index
- 84OpenAlex ·
- i10-index
- 1,274OpenAlex ·
- 2-year mean citedness
- 1.37OpenAlex ·
- Self-citation rate
- 4.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 88LetPub ·
Articles by year OpenAlex count · 3,902 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 268 | 268 | 45 |
| 2025 | 387 | 387 | 541 |
| 2024 | 449 | 449 | 931 |
| 2023 | 253 | 253 | 1,886 |
| 2022 | 266 | 266 | 1,869 |
| 2021 | 272 | 272 | 1,661 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
71 daysMedian, submission to acceptance · P25–P75 38 days – 111 days
- Acceptance to online
- median 33 days (107 articles)
- Submission to online
- median 112 days
- Sample
- 107 articles with submission and acceptance dates (300 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 13%Publisher website ·
- Submission to first decision
- 8 daysPublisher website ·
- Submission to publication (journal-reported)
- about 30 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,500 | Yes | CC BY-NC-ND | |
| OpenAlex | USD 1,500 / EUR 1,400 / GBP 1,200 / JPY 186,050 | — | — | |
| Publisher website | USD 1,500 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 1
- Manuscript length
- ≤ 4,000 words
- Reference style
- Vancouver
- Highlights
- Optional
- Graphical abstract
- Optional
Article types accepted14, with length limits
- brief reportThese submissions are reviewed as rigorously as original research items. Although they include the same sections, use the same format and follow the same guidel…main text ≤ 1,500 words
- brief reportsThese submissions are reviewed as rigorously as original research items. Although they include the same sections, use the same format and follow the same guidel…Length not stated
- clinical lettersClinical Letters will not be preceded by an abstract. The word count is strictly limited to 1,500 words excluding title page information, references, and any fi…Length not stated
- clinical practice guidelines and position papersAoH welcomes all official articles from the represented Scientific Societies referring to recommendations, practice guidelines, position papers or reports of Co…Length not stated
- concise reviewsReview articles on selected clinical and basic topics should be no longer than 5,000 words. References should not exceed a maximum of 150.Length not stated
- correspondenceWe welcome letters to the editor that comment on articles recently published in AoH. Letters should contain no more than 500 words and a minimum of 15 reference…main text ≤ 500 words · references ≤ 15
- editorialcluded in the word count. The length of editorials should not exceed 1,500 words (excluding the title, byline, and references). Opinions Themain text ≤ 1,500 words · references ≤ 15
- newsThis section contains information on the year-round academic and scientific activities developed by our affiliated associations. This section will be open for a…Length not stated
- opinionl areas of hepatology. The length of an opinion should not exceed 1,000 words. No tables or figures are allowed (exceptions are solely atmain text ≤ 1,000 words · references ≤ 15
- opinionsThese essays present opinions, hypotheses and controversial issues in all areas of hepatology. The length of an opinion should not exceed 1,000 words. No tables…Length not stated
- original articleces should not exceed a maximum of 150. Original articles The maximum length of manuscripts that describe original research is 4,000 words (excluding references…main text ≤ 4,000 words · references ≤ 50
- original articlesThe maximum length of manuscripts that describe original research is 4,000 words (excluding references). Original articles should include no more than 50 refere…Length not stated
- other publicationsCongress proceedings, generally in the form of selected abstracts, may be considered for publication. Supplements to the journal containing extended abstracts, …Length not stated
- reviewm of 15 references are allowed. Concise reviews Review articles on selected clinical and basic topics should be no longer than 5,000 words. References should no…main text ≤ 5,000 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Double anonymized peer review Model summary
This journal follows a double anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Mexican Association of Hepatology
- Country or region
- MEXICO
- Language
- English
- Frequency
- Quarterly
- Founded
- 2002
- ISSN
- 1665-2681
- Electronic ISSN
- 2659-5982
- Society / sponsor
- Mexican Association of Hepatology
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Annals of Hepatology
What CAS zone is Annals of Hepatology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Annals of Hepatology is in Zone 3 of Medicine, and in Zone 4 of the minor category Gastroenterology & Hepatology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Annals of Hepatology?
The latest impact factor listed by LetPub is 5.87; CiteScore 9.6, h-index 84.
How long does peer review take at Annals of Hepatology?
Based on the dates recorded on 107 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 71 days (interquartile range 38–111 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 13%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Annals of Hepatology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 1; Manuscript length: ≤ 4,000 words; Reference style: Vancouver; Highlights: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Annals of Hepatology based?
Of the 45 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Mexico (13), Italy (7) and Spain (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Annals of Hepatology?
According to LetPub and DOAJ records, Annals of Hepatology is indexed in SCIE, Scopus and DOAJ.
Is Annals of Hepatology open access, and what is the APC?
Annals of Hepatology is a fully open-access journal. APC about USD 1,500.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .